CluePoints Funding: How Much Did They Raise & Key Investors

How Much Did CluePoints Raise?
Funding & Key Investors

CluePoints has secured significant enterprise-level funding, with its total capital raised standing at $6.6M. The company recently announced an undisclosed amount in its latest funding round, which took place on September 1, 2020. This latest investment follows a substantial private equity round in July 2015, which brought in $6.6B, underscoring a consistent trajectory of financial backing for the company's growth and development.

What is CluePoints?

CluePoints

Software

Healthcare Software

Business Intelligence (BI) Software

CluePoints operates within the Risk-Based Quality Management sector, providing specialized solutions tailored for pharmaceutical companies and Contract Research Organizations (CROs). Its platform is engineered to enhance the identification, visualization, management, and documentation of risks that could potentially impact the outcomes of clinical trials. This focus positions CluePoints as a key player in ensuring the integrity and reliability of pharmaceutical research and development processes.

How much funding has CluePoints raised?

CluePoints has raised a total of $6.6M across 1 funding round:

2015

Private Equity

$6.6M

Private Equity (2015): $6.6M, investors not publicly disclosed

What's next for CluePoints?

The recent enterprise-level funding indicates a strategic push for CluePoints to scale its operations and potentially expand its market reach. This capital infusion is likely to be directed towards enhancing its technological capabilities, broadening its client base within the pharmaceutical and CRO industries, and further solidifying its position in the competitive landscape of clinical trial risk management. The company's continued access to significant investment suggests strong investor confidence in its business model and future growth prospects.

See full CluePoints company page

See More Financial Insights